Abuse Deterrent Opioids
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
78
NCT05572190
Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 27, 2022
Completion: Mar 31, 2024
Loading map...